| 181/318 | US=56 / Biol/Mol Fox R, Aubert M. Flow cytometric detection of activated caspase-3. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 47-56. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. CITOMETRIA DE FLUXO; CASPASE-3; APOPTOSE; COLORACAO DE IMUNOFLUORESCENCIA |
| 182/318 | US=56 / Biol/Mol Knudson CM, Brown NM. Mitochondria potential, bax "Activation," and programmed cell death. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 95-108. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. |
| 183/318 | US=56 / Biol/Mol Lee BW, Olin MR, Johnson GL, Griffin RJ. In vitro and in vivo apoptosis detection using membrane permeant fluorescent-labeled inhibitors of caspases. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 109-35. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. FLICA; IN VIVO; IN VITRO; APOPTOSE; CASPASE; IMAGEM; DETECCAO; ENSAIO DE CITOTOXICIDADE |
| 184/318 | US=56 / Biol/Mol Denault JB, Salvesen GS. Apoptotic caspase activation and activity. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 191-220. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. |
| 185/318 | US=56 / Biol/Mol Walczak H, Haas TL. Biochemical analysis of the native TRAIL death-inducing signaling complex. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 221-39. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. |
| 186/318 | US=57 / Biol/Mol Weinberg RA. p53 e apoptose: guardião e executor. In: ___. A biologia do câncer. Porto Alegre: Artmed, 2008. p. 307-56. ISBN 978-85-363-1348-1. P53; APOPTOSE; PAPOVAVIRUS; MUTACAO DE P53; ALEDOS MUTANTES HERDADOS; CELULAS CANCEROSAS |
| 187/318 | US=65 / Biol/Mol D'Alessio S, Blasi F. The urokinase plasminogen activator receptor as a target for cancer therapy. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 223-43. ISBN 978-0-387-69056-8. RECEPTOR UROQUINASE; ATIVADOR DO PLASMINOGENIO; TERAPIA DO CANCER; SISTEMA UPA/UPAR; TRANSDUCAO DE SINAL; MOTILIDADE CELULAR; PROLIFERACAO CELULAR; CANCER; ESTRATEGIAS TERAPEUTICAS ANTISENSE; APOPTOSE |
| 188/318 | US=65 / Biol/Mol Reinheckel T, Gocheva V, Peters C, Joyce JA. Roles of cysteine proteases in tumor progression: analysis of cysteine cathepsin knockout mice in cancer models. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 281-304. ISBN 978-0-387-69056-8. PROTEASES DE CISTEINA; PROGRESSAO TUMORAL; ANALISE DE RATINHOS KNOCKOUT; CISTEINA CATEPSINA; MODELOS DE CANCER; FENOTIPOS; CARCINOGENESE; CANCER CERVICAL; CANCER PANCREATICO; CANCER DE MAMA; CANCER DE PELE; ANGIOGENESE; INVASAO TUMORAL; PROLIFERACAO DE CELULAS TUMORAIS; APOPTOSE |
| 189/318 | US=65 / Biol/Mol Murthy A, Cruz-Munoz W, Khokha R. TIMPs: extracellular modifiers in cancer development. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 373-400. ISBN 978-0-387-69056-8. TIMPS; MODIFICADORES EXTRACELULARES; DESENVOLVIMENTO DO CANCER; PROLIFERACAO CELULAR; APOPTOSE; ANGIOGENESE; CONTATO CELULAR; MOTILIDADE; MODELOS IN VIVO; BIOLOGIA DO CANCER |
| 190/318 | US=65 / Biol/Mol Stoppelli MP, Andersen LM, Votta G, Andreasen PA. Engineered antagonists of uPA and PAI-1. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 721-58. ISBN 978-0-387-69056-8. UPA; PAI-1; ATIVACAO DO PLASMINOGENIO; DISSEMINACAO DO CANCER; PROPRIEDADES BIOQUIMICAS; ADESAO CELULAR; MIGRACAO CELULAR; INVASAO CELULAR; PROLIFERACAO CELULAR; SOBREVIVENCIA; APOPTOSE; ATIVIDADE ENZIMATICA |
| 191/318 | US=67 / Biol/Mol Gupta A, Kirkwood JM. Melanoma. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 343-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. MELANOMA; PATOGENESE MOLECULAR; TERAPIA ALVO; INTERFERON; STAT; ANTISENSE BC12; BRAF; APOPTOSE; CICLO CELULAR |
| 192/318 | US=58 / Câncer Kaina B, Roos WP, Christmann M. DNA damage response and the balance between cell survival and cell death. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 95-108. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; SOBREVIVENCIA CELULAR; MORTE CELULAR; CHECKPOINTS; CICLO CELULAR; RESPOSTA A DANOS DO DNA; REPARACAO DO ADN; P53; APOPTOSE; RECEPTORES DE MORTE; FAS; CAIXA ELETRONICO; ATR; DROGAS ANTICANCER |
| 193/318 | US=70 / Biol/Mol Bunz F. Cancer gene pathways. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 173-226. ISBN 978-1-4020-6783-9. CANCER; GENE; VIAS; VIAS CELULARES; INTERACAO PROTEINA-PROTEINA; REACOES BIOQUIMICAS; FOSFORILACAO DE PROTEINAS; SINAIS DA SUPERFICIE CELULAR; TIROSINA-QUINASES PROTEICAS; VIA RAS; FOSFORILACAO DE LIPIDIOS; VIA PI3K/AKT; MORFOGENESE; VIA WNT/APC; HOMEOSTASE; ATIVACAO P53; MDM2; APOPTOSE; CICLO CELULAR |
| 194/318 | US=84 / Biol/Mol Kim TA, Kim SJ. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of TGF-B-induced apoptosis in cancer cells. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 199-211. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 195/318 | US=84 / Biol/Mol Zhao Y, Hei TK. TGF-B superfamily members in normal and tumor biology: role of betaig-h3 gene in carcinogenesis. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 475-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. BETAIG-H3; CARCINOGENESE; DISTROFIAS DE CORNEA; METILACAO; PROLIFERACAO; APOPTOSE; ANTITUMORAL |
| 196/318 | US=84 / Biol/Mol Grusch M, Rodgarkia-Dara C, Bursch W, Schulte-Hermann R. TGF-B superfamily members in normal and tumor biology: activins and the liver. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 483-508. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; ATIVINAS; INIBINA; FOLLISTATINS; APOPTOSE HEPATICA; SINTESE DE ADN HEPATICO; EFEITOS INFLAMATORIOS; FIBROSE HEPATICA; MITOGENOS QUIMICOS; TUMORES HEPATICOS |
| 197/318 | US=86 / Biol/Mol Zakeri Z, Lockshin RA. Cell dealth: history and future. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 1-11. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. MORTE CELULAR; APOPTOSE; AUTOFAGIA; MORTE CELULAR AUTOFAGICA; HISTORICO; LISOSSOMA |
| 198/318 | US=86 / Biol/Mol Salvesen GS, Riedl SJ. Caspase mechanisms. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 13-23. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. CASPASE; MECANISMOS DE CASPASE; APOPTOSSOMO; DISC; IAP; INIBICAO; PROTEASE; ZIMOGENIO; APOPTOSE |
| 199/318 | US=86 / Biol/Mol Chalah A, Khosravi-Far R. The mitochondrial death pathway. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 25-45. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. VIA DE MORTE MITOCONDRIAL; APOPTOSE; RECEPTORES DE MORTE; MITOCONDRIAS; MEMBRANAS; FOSFOLIPASES; CARDIOLIPINA; LIBERACAO DE FATORES PRO-APOPTOTICOS; CITOCROMO C; FATOR DE INDUCAO DE APOPTOSE; SMAC / DIABLO; HTRA2/OMI; ENDONUCLEASE G; PROTEINAS MITOCONDRIAIS; ATIVACAO DA CASPASE; FAMILIA BCL-2; STRESS OXIDATIVO; CANCER |
| 200/318 | US=86 / Biol/Mol Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R. Apoptotic pathways in tumor progression and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 47-79. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. VIAS APOPTOTICAS; PROGRESSAO TUMORAL; TERAPIA DE CANCER; APOPTOSE; INIBIDORES; TRANSDUCAO DE SINAL; ONCOGENE; MAQUINARIA APOPTOTICA; DROGAS QUIMIOTERAPICAS; RESISTENCIA A DROGA |